Clinical oncology innovation
CancerFree Biotech
Aligned with oncology research, patient-centred translational pathways, and advanced therapeutic innovation.
Executive-only • Curated admission • Limited seats
|
Dates: 20–22 January 2027
|
City: Singapore
Strategic collaboration • Executive visibility • High-trust engagement
ECTMBICS 2027 Partners
ECTMBICS 2027 welcomes strategic partners aligned with translational medicine, clinical research, biotechnology, pharmaceutical strategy, digital health, regulatory science, precision medicine, healthcare innovation, investment, and clinical commercialisation.
Audience quality
Executive-first
Curated decision-makers, clinical leaders, biotech executives, and selected senior experts.
Partnership value
Visibility + outcomes
Meaningful access to healthcare innovators, biotech leaders, clinical researchers, and strategic partners.
Why partner with ECTMBICS?
Partnering with ECTMBICS positions your organisation alongside executive-level dialogue on translational medicine, biotech innovation, clinical strategy, digital health, and healthcare implementation.
Visibility
Brand presence across priority touchpoints
Program, website, networking, and curated introductions
Engagement
Access to senior delegates and invited leaders
High-relevance conversations over mass exposure
Positioning
Association with clinical and biotech innovation
Translational medicine, pharma strategy, digital health, and healthcare impact
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Strategic partnership pathways
Visibility • introductions • executive relevance
Partnership focus
Built for selective, high-value collaborations rather than broad promotional placement.
Brand positioning
Executive-level visibility
Networking
Curated introductions
Themes
Clinical + biotech + healthcare innovation
Support
Tailored collaboration scope
Who we work well with
We welcome collaborations with organisations that bring real relevance to the congress themes and contribute value to executive participants.
Clinical & research partners
Hospitals, clinical research organisations, medical centres, academic research institutes, and translational medicine groups.
Biotech & pharma organisations
Biotechnology companies, pharmaceutical groups, therapeutic platforms, diagnostics innovators, and commercialisation teams.
Digital health & data ecosystems
AI healthcare platforms, digital medicine groups, clinical data companies, precision medicine and decision-support innovators.
Strategic institutions
Healthcare investors, accelerators, international associations, regulatory networks, innovation hubs, and industry partners.
What partnership can include
Collaboration models can be tailored depending on alignment, scale, and congress objectives.
Strategic visibility
Website listing, selected acknowledgements, curated visibility in event communication materials, and branded presence where relevant.
Thought leadership alignment
Support for executive roundtables, clinical strategy sessions, biotech innovation discussions, panel contributions, or aligned session formats where approved by the organising team.
Curated networking support
Selective introductions or partner-facing engagement opportunities based on mutual relevance and executive fit.
Custom collaboration opportunities
Tailored options may be considered for strategic healthcare institutions, biotech companies, pharma partners, investment groups, accelerators, and knowledge-sector partners.
Our partnership approach
01
Relevance first
We prioritise alignment over volume.
02
Executive fit
Every collaboration should support the delegate experience.
03
Outcome orientation
We favour practical value over generic exposure.
Partner network
ECTMBICS 2027 brings together selected organisations connected to biotech innovation, clinical translation, digital health, AI-enabled diagnostics, advanced therapeutics, and healthcare commercialisation. The organisations below are displayed as integrated collaboration partners, supporting both strategic visibility and industry engagement across the congress.
AI diagnostics & pathology
Qritive
Connected to AI-supported clinical diagnostics, digital pathology, workflow intelligence, and healthcare decision support.
Medical AI & imaging
VinBrain
Relevant to AI-powered medical imaging, healthcare data platforms, and scalable clinical implementation.
Diagnostics & biosensing
Nanotis
Supports the congress focus on biosensing, diagnostic technologies, and practical health innovation pathways.
Healthcare technology collaboration
Gyder
Positioned within the broader digital health, healthcare technology, and innovation partnership landscape.
Applied science & innovation
Intermag
Represents interdisciplinary innovation connected to applied science, research translation, and industry-facing collaboration.
Strategic technology partner
Armastec
Included as a technology-oriented collaboration partner supporting cross-sector visibility and executive engagement.
Integrated partner visibility
The above organisations are presented as combined partner collaborators for ECTMBICS 2027. The page intentionally avoids separating them into sponsor-only or exhibitor-only categories, as each organisation may contribute through brand presence, knowledge exchange, networking, and strategic engagement depending on final collaboration scope.